Volk, Michael L.

Publishing since 2006 (Baby)

Has published 16 publications in 5 years

Number of publications published per year by Volk, Michael L.. (Source : PubMed)

Distribution of publications types for Volk, Michael L.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Volk ML, Hanson CV, Israel-Ballard K, Chantry CJ. Inactivation of cell-associated and cell-free HIV-1 by flash-heat treatment of breast milk.  J. Acquir. Immune Defic. Syndr.  2010;53;5  
•  Singal AG, Volk ML, Jensen D, Di Bisceglie AM, Schoenfeld PS. A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus.  Clin. Gastroenterol. Hepatol.  2010;8;3  
•  Volk ML, Warren GJ, Anspach RR, Couper MP, Merion RM, Ubel PA. Attitudes of the American Public toward Organ Donation after Uncontrolled (Sudden) Cardiac Death.  Am. J. Transplant.  2010  
•  Vitale A, Volk ML, Pastorelli D, Lonardi S, Farinati F, Burra P, Angeli P, Cillo U. Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety.  Hepatology  2010;51;1  
•  Duan KI, Englesbe MJ, Volk ML. Centers for Disease Control 'High-Risk' Donors and Kidney Utilization.  Am. J. Transplant.  2009  
•  Volk ML, Tocco R, Saini S, Lok AS. Public health impact of antiviral therapy for hepatitis C in the United States.  Hepatology  2009;50;6  
•  Volk ML, Choi H, Warren GJ, Sonnenday CJ, Marrero JA, Heisler M. Geographic variation in organ availability is responsible for disparities in liver transplantation between Hispanics and Caucasians.  Am. J. Transplant.  2009;9;9  
•  Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, Marrero JA. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.  Aliment. Pharmacol. Ther.  2009;30;1  
•  Volk ML, Lok AS. Is family history of liver cancer a risk factor for hepatocellular carcinoma?  J. Hepatol.  2009;50;2  
•  Volk ML, Lok AS, Pelletier SJ, Ubel PA, Hayward RA. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.  Gastroenterology  2008;135;5  

[ See timeline ] [ See all publications ]